SABCS ® "Spotlight” poster to be presented on Wednesday, December 11, 2024 7:00 AM - 8:30 AM CST highlights positive BriaCell survival and clinical benefit data across all metastatic breast cancer ...
Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...